Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Intestinal Preservation Injury: A Comparison Between Rat, Porcine and Human Intestines.

Søfteland JM, Casselbrant A, Biglarnia AR, Linders J, Hellström M, Pesce A, Padma AM, Jiga LP, Hoinoiu B, Ionac M, Oltean M.

Int J Mol Sci. 2019 Jun 27;20(13). pii: E3135. doi: 10.3390/ijms20133135.

2.

Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option?

Mastellos DC, Reis ES, Biglarnia AR, Waldman M, Quigg RJ, Huber-Lang M, Seelen MA, Daha MR, Lambris JD.

Clin Immunol. 2019 Jan;198:102-105. doi: 10.1016/j.clim.2018.11.010. Epub 2018 Nov 22.

PMID:
30472267
3.

The multifaceted role of complement in kidney transplantation.

Biglarnia AR, Huber-Lang M, Mohlin C, Ekdahl KN, Nilsson B.

Nat Rev Nephrol. 2018 Dec;14(12):767-781. doi: 10.1038/s41581-018-0071-x. Review.

PMID:
30367174
4.

Safety profile after prolonged C3 inhibition.

Reis ES, Berger N, Wang X, Koutsogiannaki S, Doot RK, Gumas JT, Foukas PG, Resuello RRG, Tuplano JV, Kukis D, Tarantal AF, Young AJ, Kajikawa T, Soulika AM, Mastellos DC, Yancopoulou D, Biglarnia AR, Huber-Lang M, Hajishengallis G, Nilsson B, Lambris JD.

Clin Immunol. 2018 Dec;197:96-106. doi: 10.1016/j.clim.2018.09.004. Epub 2018 Oct 10.

5.

Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic Shock.

van Griensven M, Ricklin D, Denk S, Halbgebauer R, Braun CK, Schultze A, Hönes F, Koutsogiannaki S, Primikyri A, Reis E, Messerer D, Hafner S, Radermacher P, Biglarnia AR, Resuello RRG, Tuplano JV, Mayer B, Nilsson K, Nilsson B, Lambris JD, Huber-Lang M.

Shock. 2019 Jan;51(1):78-87. doi: 10.1097/SHK.0000000000001127.

6.

Complement Interception Across Humoral Incompatibility in Solid Organ Transplantation: A Clinical Perspective.

Biglarnia AR, Ekdahl KN, Nilsson B.

Adv Exp Med Biol. 2015;865:211-33. doi: 10.1007/978-3-319-18603-0_13. Review.

PMID:
26306452
7.

Utilization of small pediatric donors including infants for pancreas and kidney transplantation: exemplification of the surgical technique and the surveillance.

Biglarnia AR, Bennet W, Nilsson T, Larsson E, Magnusson A, Yamamoto S, Lorant T, Sedigh A, von Zur-Mühlen B, Bäckman L, Korsgren O, Tufveson G.

Ann Surg. 2014 Aug;260(2):e5-7. doi: 10.1097/SLA.0000000000000751. No abstract available.

PMID:
24854454
8.

Positron emission tomography ligand [11C]5-hydroxy-tryptophan can be used as a surrogate marker for the human endocrine pancreas.

Eriksson O, Espes D, Selvaraju RK, Jansson E, Antoni G, Sörensen J, Lubberink M, Biglarnia AR, Eriksson JW, Sundin A, Ahlström H, Eriksson B, Johansson L, Carlsson PO, Korsgren O.

Diabetes. 2014 Oct;63(10):3428-37. doi: 10.2337/db13-1877. Epub 2014 May 21.

9.

[Transplantation of pancreas, a curative option for type 1 diabetes].

Biglarnia AR, Yamamoto S, Gustafsson BI, Berne C, Wagner M, Von Zur-Mühlen B, Tufveson G.

Lakartidningen. 2012 Sep 26-Oct 9;109(39-40):1754-7. Review. Swedish. No abstract available.

PMID:
23097884
10.

[Blood type incompatible kidneys can be transplanted. ABO incompatibility is no longer a barrier for kidney transplantation].

Tydén G, Nordén G, Biglarnia AR, Björk P.

Lakartidningen. 2012 Sep 26-Oct 9;109(39-40):1738. Swedish. No abstract available.

PMID:
23097878
11.

Measurement of transplanted pancreatic volume using computed tomography: reliability by intra- and inter-observer variability.

Lundqvist E, Segelsjö M, Andersson A, Magnusson A, Biglarnia AR.

Acta Radiol. 2012 Nov 1;53(9):966-72. doi: 10.1258/ar.2012.120317. Epub 2012 Sep 21.

PMID:
23002143
12.

The free radical scavenger S-PBN significantly prolongs DSG-mediated graft survival in experimental xenotransplantation.

Biglarnia AR, Emanuelsson C, Quach M, Clausen F, Larsson E, Schneider MK, Tufveson G, Lorant T.

Xenotransplantation. 2012 May-Jun;19(3):166-76. doi: 10.1111/j.1399-3089.2012.00700.x.

PMID:
22702468
13.

Vascular reconstruction using allogeneic homografts in a renal transplant patient with pseudoaneurysm and infected vascular prosthesis.

Berglund D, Bergqvist D, Lundqvist E, Magnusson A, Sedigh A, Bäckman L, Biglarnia AR.

Transplantation. 2012 Feb 27;93(4):e15-6. doi: 10.1097/TP.0b013e31824198b5. No abstract available.

PMID:
22314310
14.

Desensitization with antigen-specific immunoadsorption interferes with complement in ABO-incompatible kidney transplantation.

Biglarnia AR, Nilsson B, Nilsson Ekdahl K, Tufveson G, Nilsson T, Larsson E, Wadström J.

Transplantation. 2012 Jan 15;93(1):87-92. doi: 10.1097/TP.0b013e31823bb689.

PMID:
22113493
15.

Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation.

Biglarnia AR, Nilsson B, Nilsson T, von Zur-Mühlen B, Wagner M, Berne C, Wanders A, Magnusson A, Tufveson G.

Transpl Int. 2011 Aug;24(8):e61-6. doi: 10.1111/j.1432-2277.2011.01290.x. Epub 2011 Jun 22.

16.

Ureteroperitoneostomy--a rare complication after kidney transplantation.

Lundqvist E, Tufveson G, Duraj F, Wadström J, Biglarnia AR.

Transpl Int. 2011 Sep;24(9):e75-6. doi: 10.1111/j.1432-2277.2011.01281.x. Epub 2011 Jun 7. No abstract available.

17.

Liver regeneration is impaired by FK778 in partially hepatectomized rats, while supplemental uridine restores both liver growth and hepatocyte proliferation.

Biglarnia AR, Lorant T, Lee HS, Tufveson G, Tötsch M, Malagó M.

Hepatol Res. 2009 Jan;39(1):86-92. doi: 10.1111/j.1872-034X.2008.00402.x. Epub 2008 Aug 18.

PMID:
18713276
19.

Role and significance of plasma citrulline in the early phase after small bowel transplantation in pigs.

Nadalin S, Biglarnia AR, Testa G, Koppara TR, Schaffer R, Johnson C, Toetsch M, Broelsch CE, Malagó M.

Transpl Int. 2007 May;20(5):425-31. Epub 2007 Feb 20.

Supplemental Content

Loading ...
Support Center